rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
35, 95% CI: 1.09-1.67), and rs3746444 was associated with liver cancer in the subgroup of cance</span>r types.
|
23725137 |
2013 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
A recent study indicates that inflammation and abnormal immune responses may promote malignant progression in cancer development, indicating that inflammation-related polymorphisms such as miR-146a rs2910164 and miR-499 rs3746444 are crucial.
|
25108400 |
2014 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Here, we evaluated 101 paired samples (cancer and normal tissues) from non-small cell lung carcinoma (NSCLC) patients to study the genotype distribution of single nucleotide polymorphisms (SNPs) in miR-146a (rs2910164 C-G), miR-149 (rs2292832 C-T), miR-196a2 (rs11614913 C-T) and miR-499 (rs3746444 G-A) and their influence on the expression of respective miRNAs.
|
21902575 |
2011 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
In conclusion, our meta-analysis suggests that hsa-mir-499 rs3746444 A>G polymorphism is not associated with risk of cancer</span> based on current evidence.
|
25640376 |
2015 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
In conclusion, this meta-analysis suggests that the miR-499 rs3746444 polymorphism (A>G) is a low-penetrant risk factor for cancer development among Asians and may contribute to breast cancer susceptibility.
|
23053947 |
2012 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
In summary, miR-196a2 rs11614913, miR-146a rs2910164, and miR-499 rs37</span>46444 are risk factors for cancer development, whereas mir-149 rs2292832 and miR-27a rs895919 are not associated with cancer risk.
|
24278149 |
2013 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
In the subgroup analysis by cancer types, no risk of breast, liver, or lung cancers were found significantly associated with microRNA-499 rs3746444 A/G polymorphism in any of the genetic models.
|
24258110 |
2014 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
It is concluded that two SNPs prsent in miRNAs(rs11614913TT, and rs2910164C) may protect against the pathogenesis of some cancers, and that the rs3746444 may increase risk for cancer.
|
23155448 |
2012 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
MicroRNA-499 rs3746444 was found to be significantly associated with increased risk of cancer of the respiratory system (CC vs. TT: OR = 1.575, 95% CI = 1.268-1.955, CC vs. TC+TT: OR = 1.527, 95% CI = 1.232-1.892), digestive system (CC vs. TT: OR = 1.153, 95% CI = 1.027-1.295; TC vs. TT: OR = 1.109, 95% CI = 1.046-1.176; CC+TC vs. TT: OR = 1.112, 95% CI = 1.018-1.216; CC vs. TC+TT: OR = 1.137, 95% CI = 1.016-1.272; C vs. T: OR = 1.112, 95% CI = 1.025-1.206), urinary system (TC vs. TT: OR = 1.307, 95% CI = 1.130-1.512; CC+TC vs. TT: OR = 1.259, 95% CI = 1.097-1.446; C vs. T: OR = 1.132, 95% CI = 1.014-1.264), and gynecological system (C vs. T: OR = 1.169, 95% CI = 1.002-1.364).
|
29946268 |
2018 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
MicroRNAs (miRNAs) miRNA-499 rs3746444 A>G polymorphism may be complicated in the susceptibility to cancer.
|
31496728 |
2019 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Multivariate survival analysis using the Cox's regression model revealed that non-responder by the RECIST (Hazard ratio (HR): 2.14 95%CI 1.06-4.19), upper third cancer (HR: 2.48 95%CI 1.12-5.49) and more advanced stage (HR: 4.12 95%CI 1.06-16.02) were predictive factors for worse OS, while the rs3746444 A allele carrier was predictive factor for better OS (HR: 0.33 95%CI 0.18-0.75).
|
25202115 |
2014 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our findings support the view that miR-499 rs3746444 T>C polymorphism is associated with breast cancer and the C allele can increase cancer susceptibility in Asian.
|
23271127 |
2013 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our meta-analysis suggested that hsa-mir-499 rs3746444 T > C polymorphism is associated with the risk of cancer in Asians, mainly in Iranian and Chinese population.
|
25433484 |
2014 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our meta-analysis suggests that the rs11614913 most likely contributes to decreased susceptibility to cancer, especially in Asians and colorectal cancer and gastric cancer, and that the rs3746444 may increase risk for cancer.
|
29371991 |
2017 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Overall, hsa-miR-499 rs3746444 polymorphism was associated with higher cancer risk in heterozygote model (AG vs AA, OR=1.15, 95%CI=1.01-1.30, P(heterogeneity)<0.001), dominant genetic model (GG/AG vs AA, OR=1.18, 95% CI=1.04-1.33, P(heterogeneity)<0.001) and allele contrast (G vs A, OR=1.09, 95% CI=1.01-1.18, P(heterogeneity)=0.021).
|
22922391 |
2012 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The present study was aimed to investigate the association between four highly studied miRNA polymorphisms (mir-146a rs2910164, mir-196a2 rs11614913, mir-149 rs2292832 and mir-499 rs3746444) and cancer risk by using a two-sided meta-analytic approach.
|
23226435 |
2012 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
There were not significant associations between miR-146a rs2910164 and miR-499 rs3746444 polymorphisms with overall cancer risk.
|
23292097 |
2013 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
These findings indicate that the miR-499 rs3746444 polymorphism is associated with an increased cancer risk.
|
24085457 |
2013 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
These meta-analysis results suggest that hsa-miR-499 polymorphism rs3746444 is associated with a significantly increased risk of cancer, especially in Asian populations.
|
23236400 |
2012 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
This meta-analysis suggests a significant association between miR-499 rs3746444 polymorphism and cancer risk.
|
22970328 |
2012 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Thus, we aimed to investigate the association of MIR196a2 rs11614913 (C/T), MIR499a rs3746444 (A/G) polymorphisms and their combination with cancer susceptibility in an Egyptian population.
|
27509977 |
2016 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
We further performed functional studies of three microRNA variants associated with cancer (rs2910164:C > G in MIR146A, rs11614913:C > T in MIR196A2, and rs3746444:A > G in both MIR499A and MIR499B).
|
27397105 |
2016 |
rs3746444
|
|
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Whereas, rs3746444 G allele was a risk factor in Chinese population, and the association varied from different cancer types.
|
23750236 |
2013 |